Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.19
+1.7%
$1.30
$0.90
$2.93
$58.51M-0.9525,358 shs9,611 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$2.74
+6.2%
$2.05
$1.03
$6.30
$95.86M-0.14171,370 shs54,508 shs
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$3.42
+0.9%
$3.29
$1.12
$3.40
$157.21M0.51735,945 shs3.27 million shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$126.81
+3.4%
$120.99
$53.71
$136.00
$3.52B1.98489,544 shs575,837 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
+2.15%+1.71%-7.75%-20.03%-32.00%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
+6.20%+33.01%+86.39%-17.84%-27.51%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
0.00%0.00%+4.56%+8.54%+180.25%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
+3.36%+8.04%+0.67%+53.60%+131.24%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.19
+1.7%
$1.30
$0.90
$2.93
$58.51M-0.9525,358 shs9,611 shs
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$2.74
+6.2%
$2.05
$1.03
$6.30
$95.86M-0.14171,370 shs54,508 shs
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$3.42
+0.9%
$3.29
$1.12
$3.40
$157.21M0.51735,945 shs3.27 million shs
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$126.81
+3.4%
$120.99
$53.71
$136.00
$3.52B1.98489,544 shs575,837 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
+2.15%+1.71%-7.75%-20.03%-32.00%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
+6.20%+33.01%+86.39%-17.84%-27.51%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
0.00%0.00%+4.56%+8.54%+180.25%
GeneDx Holdings Corp. stock logo
WGS
GeneDx
+3.36%+8.04%+0.67%+53.60%+131.24%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
1.00
SellN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
2.50
Moderate BuyN/AN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
2.33
HoldN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.50
Moderate Buy$104.13-17.89% Downside

Current Analyst Ratings Breakdown

Latest ATPC, EUDA, WGS, and THTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/8/2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
10/2/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
9/27/2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
9/27/2025
Theratechnologies Inc. stock logo
THTX
Theratechnologies
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
9/27/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
9/11/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$120.00 ➝ $140.00
8/4/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetOverweight$110.00 ➝ $120.00
7/30/2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$78.00 ➝ $95.00
(Data available from 10/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.32M45.08N/AN/A$0.48 per share2.48
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
$4.01M25.39N/AN/A($0.07) per share-39.14
Theratechnologies Inc. stock logo
THTX
Theratechnologies
$84.38M1.86N/AN/A($0.55) per share-6.22
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$305.45M11.93$1.06 per share119.90$8.75 per share14.49
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.41N/AN/A-183.13%-20.32%-18.55%11/12/2025 (Estimated)
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
-$15.36MN/A0.00N/AN/AN/AN/AN/AN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
-$8.31M-$0.19N/A48.84N/A-10.85%N/A-9.83%N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$52.29M$0.052,536.2060.67N/A0.39%16.51%9.35%10/28/2025 (Estimated)

Latest ATPC, EUDA, WGS, and THTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
10/28/2025Q3 2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.33N/AN/AN/A$104.33 millionN/A
8/13/2025Q2 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.01N/A-$0.01N/AN/A
7/29/2025Q2 2025
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.10$0.50+$0.40$0.36$86.00 million$102.69 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/AN/AN/AN/AN/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/AN/AN/AN/AN/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
20.36
20.33
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
0.23
0.21
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
0.84
0.65
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.19
2.87
2.70

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
4.35%
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
N/A
Theratechnologies Inc. stock logo
THTX
Theratechnologies
N/A
GeneDx Holdings Corp. stock logo
WGS
GeneDx
29.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
EUDA Health Holdings Limited stock logo
EUDA
EUDA Health
237.16 millionN/ANot Optionable
Theratechnologies Inc. stock logo
THTX
Theratechnologies
14045.98 millionN/AOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,20028.73 million20.22 millionOptionable

Recent News About These Companies

GeneDx's (WGS) Sell (D) Rating Reaffirmed at Weiss Ratings
GeneDx (NASDAQ:WGS) Trading Down 6.9% - Should You Sell?
GeneDx (NASDAQ:WGS) Trading Down 4% - What's Next?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.19 +0.02 (+1.71%)
Closing price 10/9/2025 03:50 PM Eastern
Extended Trading
$1.19 0.00 (0.00%)
As of 07:19 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

EUDA Health stock logo

EUDA Health NASDAQ:EUDA

$2.74 +0.16 (+6.20%)
Closing price 10/9/2025 03:55 PM Eastern
Extended Trading
$2.71 -0.03 (-0.95%)
As of 07:55 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

Theratechnologies stock logo

Theratechnologies NASDAQ:THTX

$3.42 +0.03 (+0.86%)
Closing price 09/25/2025
Extended Trading
$3.42 0.00 (0.00%)
As of 09/25/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada.

GeneDx stock logo

GeneDx NASDAQ:WGS

$126.81 +4.12 (+3.36%)
Closing price 10/9/2025 04:00 PM Eastern
Extended Trading
$127.44 +0.63 (+0.50%)
As of 08:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.